Skip to main content
Equibles

Tower Research Capital LLC (TRC)

Position in MTVA — MetaVia Inc.

CIK 1533421 NEW YORK, NY
Back to MTVA Full portfolio

Position in MTVA

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$3,178
+$56 QoQ
Shares Held
2,223
-14.6% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 17 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MTVA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,738,477 across 465 Biotechnology names. MTVA ranks #406 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 4,547 $4,218,570
2 BBIO
BridgeBio Pharma, Inc.
 38,206 $2,845,582
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 34,537 $2,815,110
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,292 $2,131,964
5 MDGL
Madrigal Pharmaceuticals, Inc.
 3,927 $2,108,602
6 AXSM
Axsome Therapeutics, Inc.
 6,437 $1,575,584
7 INSM
INSMED Inc
 10,927 $1,165,036
8 ROIV
Roivant Sciences Ltd.
 32,746 $1,158,880

All Filings in MTVA

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,178 2,223
2026-03-31 $3,122 2,602
2025-12-31 $2,054 244
2025-09-30 $7,465 7,942
2025-06-30 $2,628 4,088
2025-03-31 $3,736 2,426
2024-12-31 $4,512 2,223
2024-09-30 $4,536 1,431
2024-06-30 $4,922 1,017
2024-03-31 $6,760 1,653
2023-12-31 $7,981 2,159